Your browser doesn't support javascript.
loading
Amyloidosis and COVID-19: experience from an amyloid program in Canada.
Lewis, Ellen; Fine, Nowell; Miller, Robert J H; Hahn, Christopher; Chhibber, Sameer; Mahe, Etienne; Tay, Jason; Duggan, Peter; McCulloch, Sylvia; Bahlis, Nizar; Neri, Paola; Jimenez-Zepeda, Victor H.
Afiliação
  • Lewis E; Division of Hematology, Department of Medicine, University of Calgary, Calgary, AB, Canada.
  • Fine N; Division of Cardiology, Department of Cardiac Sciences, Libin Cardiovascular Institute, University of Calgary, Calgary, AB, Canada.
  • Miller RJH; Division of Cardiology, Department of Cardiac Sciences, Libin Cardiovascular Institute, University of Calgary, Calgary, AB, Canada.
  • Hahn C; Division of Neurology, Department of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada.
  • Chhibber S; Division of Neurology, Department of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada.
  • Mahe E; Department of Pathology and Lab Medicine, University of Calgary, Calgary, AB, Canada.
  • Tay J; Division of Hematology, Department of Medicine, University of Calgary, Calgary, AB, Canada.
  • Duggan P; Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
  • McCulloch S; Charbonneau Cancer Research Institute, Calgary, AB, Canada.
  • Bahlis N; Division of Hematology, Department of Medicine, University of Calgary, Calgary, AB, Canada.
  • Neri P; Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
  • Jimenez-Zepeda VH; Division of Hematology, Department of Medicine, University of Calgary, Calgary, AB, Canada.
Ann Hematol ; 101(10): 2307-2315, 2022 Oct.
Article em En | MEDLINE | ID: mdl-36028582

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neuropatias Amiloides Familiares / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neuropatias Amiloides Familiares / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article